10x Genomics Inc. (TXG)
NASDAQ · Healthcare
10x Genomics Inc. Shareholder Equity 2017–2025
10x Genomics Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- 10x Genomics Inc. shareholder equity as of December 31, 2025: 796.3M, a 12.14% increase year-over-year.
- 10x Genomics Inc. shareholder equity for 2025 were 796.3M, a 12.14% increase from 2024.
- 10x Genomics Inc. shareholder equity for 2024 were 710.1M, a 4.17% decrease from 2023.
- 10x Genomics Inc. shareholder equity for 2023 were 741.0M, a 8.03% decrease from 2022.
- 10x Genomics Inc. shareholder equity for 2022 were 805.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| 10x Genomics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $796 |
| 2024 | $710 |
| 2023 | $741 |
| 2022 | $806 |
| 2021 | $818 |
| 2020 | $739 |
| 2019 | $420 |
| 2018 | $-220 |
10x Genomics Inc. Shareholder Equity — FAQ
10x Genomics Inc. (TXG) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TXG's shareholder equity history?
The chart and table above show 10x Genomics Inc.'s shareholder equity by year and by quarter, including the growth rate.